| Code | 1311C | ||||||||||
| MA number | 13/0443/16-S | ||||||||||
| Product Form: | plv ifo 1x300 mg (liek.inj.skl.-žltá plomba) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Amomed Pharma GmbH, Austria | ||||||||||
| Therapeutic Class: | 13 - ANTIARRYTHMICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 29.09.2016 |
| SPC: |
SPC_Rapibloc 300 mg prášok na infúzny roztok_11_2024.pdf
|
| PIL: |
PIL_Rapibloc 300 mg prášok na infúzny roztok_11_2024.pdf
|
| Safety feature | Yes |
| Data update: | 28.10.2021 |
